Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
NCT ID: NCT05032833
Last Updated: 2022-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
36 participants
INTERVENTIONAL
2021-09-22
2022-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
NCT05698095
Pharmacokinetics of GH001 in Healthy Volunteers
NCT05163691
Safety of GH001 in Healthy Volunteers
NCT04640831
Acute Dose-dependent Effects of DMT in Healthy Subjects
NCT05384678
Safety and Tolerability of DMT in Healthy Adults
NCT05901012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
5-MeO-DMT arm
5-MeO-DMT
A single dose of 5-MeO-DMT will be administered intranasally
Placebo arm
Placebo
A single dose of placebo will be administered intranasally
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
5-MeO-DMT
A single dose of 5-MeO-DMT will be administered intranasally
Placebo
A single dose of placebo will be administered intranasally
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beckley Psytech Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
King's College London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BPL-5MEO-101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.